Elite Pharmaceuticals, Inc. (ELTP) .
本页证实的标准:
SharesGrow 综合评分： 61/100 其中 2/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $0.00 | $12.5M | $-683.01K | -5.5% |
| 2017 | $-0.01 | $9.64M | $3.81M | 39.5% |
| 2018 | $0.00 | $7.46M | $-3.67M | -49.2% |
| 2019 | $-0.01 | $7.57M | $-9.28M | -122.6% |
| 2020 | $0.00 | $17.99M | $-2.24M | -12.5% |
| 2021 | $0.01 | $25.38M | $5.09M | 20% |
| 2022 | $0.01 | $32.26M | $8.9M | 27.6% |
| 2023 | $4.35 | $34.16B | $4.41B | 12.9% |
| 2024 | $0.02 | $56.63M | $20.11M | 35.5% |
| 2025 | $0.00 | $84.04M | $-4.31M | -5.1% |
